
Tempest Therapeutics, Inc.
TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31
Reports and events: 308 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2012-12-0716:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-12-082742 |
| 2012-11-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-077343 |
| 2012-11-1318:25 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001104659-12-077250 |
| 2012-11-0913:42 ET | 8-K | 8.01 Other events | 0001104659-12-076307 |
| 2012-10-3020:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-12-072305 |
| 2012-08-2922:25 ET | S-1 | Registration statement | 0001047469-12-008575 |
| 2012-08-1417:36 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001104659-12-057721 |
| 2012-08-1412:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-12-057589 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.